DJIA 17,374.69 179.27 1.04%
NASDAQ 4,628.12 61.98 1.36%
S&P 500 2,013.43 18.78 0.94%
market minute promo

11.80 -0.26 (-2.16%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BCRX $11.80 -2.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.41
Previous Close $12.06
Daily Range $11.69 - $12.74
52-Week Range $4.55 - $14.62
Market Cap $846.7M
P/E Ratio -19.14
Dividend (Yield) $0.00 (0.0%)
Volume 588,648
Average Daily Volume 1,677,439
Current FY EPS -$0.84





BioCryst Pharmaceuticals, Inc. (BCRX) Description

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Website:

News & Commentary Rss Feed

3 Biotech Stocks Near 52-Week Highs Worth Selling

Three Motley Fool analysts weigh in on which stocks they think should be sold near their highs.

Hazmat-suit maker’s shares jump on Ebola orders

Ebola Vaccine Contenders

Ebola Hits NYC: Time To Panic

Ebola: The making of a $1 billion drug

BioCryst Pharmaceutical: Short-Term Pump-And-Dump On Ebola Fear, A Long-Term Hold On Pipeline

The Ebola stocks: Effect of an outbreak

The Ebola stocks: The outbreak effect

New Ebola Fears in NYC Make Major Ebola Stock Waves

Ebola Stock Fallout Severe on Monday

Healthcare Stocks in Focus on Ebola Fears - Analyst Blog

See More BCRX News...

BCRX's Top Competitors

BCRX $11.80 (-2.16%)
Current stock: BCRX
AMGN $163.32 (1.08%)
Current stock: AMGN
GILD $112.27 (-1.71%)
Current stock: GILD
BIIB $322.02 (0.32%)
Current stock: BIIB